How to make medicines for #diabetes more affordable in the USA #ADA2025 diabetesjournals.org/care/article...
June 21, 2025 at 1:42 PM
How to make medicines for #diabetes more affordable in the USA #ADA2025 diabetesjournals.org/care/article...
Take a look back at some past Council Activities. ⏪⏪ #tbt #DisabilityPrideMonth #DisabilityPride #ADA! #ADA2025 #DisabilityPride2025
July 24, 2025 at 1:17 PM
Take a look back at some past Council Activities. ⏪⏪ #tbt #DisabilityPrideMonth #DisabilityPride #ADA! #ADA2025 #DisabilityPride2025
From #ADA2025 - Once-weekly, fixed-dose insulin #efsitora has been found noninferior to insulin #glargine at reducing glycated hemoglobin levels in people with #T2D.
Full story 👉 buff.ly/xjwKO77
#MedNews #Insulin
Full story 👉 buff.ly/xjwKO77
#MedNews #Insulin
Weekly fixed-dose basal insulin noninferior to glargine for type 2 diabetes control
Once-weekly, fixed-dose insulin efsitora has been found noninferior to insulin glargine at reducing glycated hemoglobin levels in people with type 2 diabetes.
buff.ly
July 10, 2025 at 10:54 AM
From #ADA2025 - The stem cell therapy #zimislecel reduces the need for exogenous insulin treatments and restores islet function in patients with #T1D.
Full story 👉 buff.ly/rK9Lopn
#DiabetesSky #MedSky
Full story 👉 buff.ly/rK9Lopn
#DiabetesSky #MedSky
Zimislecel promotes islet cell rejuvenation in type 1 diabetes
The stem cell therapy zimislecel reduces the need for exogenous insulin treatments and restores islet function in patients with type 1 diabetes.
www.springermedicine.com
July 8, 2025 at 10:54 AM
From #ADA2025 - The stem cell therapy #zimislecel reduces the need for exogenous insulin treatments and restores islet function in patients with #T1D.
Full story 👉 buff.ly/rK9Lopn
#DiabetesSky #MedSky
Full story 👉 buff.ly/rK9Lopn
#DiabetesSky #MedSky
Heading to #ADASciSession in Chicago? Meet the #dkNET team at Booth #947 during the ADA Network Reception (June 20, 6:30–8:30 PM CT) and exhibition hours at #ADA2025!
👋 Learn about dkNET's new features & the NIDDK Data Science Corner!
🔗 dknet.org/about/blog/2...
#DiabetesResearch #datascience
👋 Learn about dkNET's new features & the NIDDK Data Science Corner!
🔗 dknet.org/about/blog/2...
#DiabetesResearch #datascience
June 18, 2025 at 4:07 PM
Heading to #ADASciSession in Chicago? Meet the #dkNET team at Booth #947 during the ADA Network Reception (June 20, 6:30–8:30 PM CT) and exhibition hours at #ADA2025!
👋 Learn about dkNET's new features & the NIDDK Data Science Corner!
🔗 dknet.org/about/blog/2...
#DiabetesResearch #datascience
👋 Learn about dkNET's new features & the NIDDK Data Science Corner!
🔗 dknet.org/about/blog/2...
#DiabetesResearch #datascience
The Banting Award for scientific achievement to Professor Steven Kahn. A stellar career with scientific leadership across multiple domains #diabetes A poignant celebration unfolds #ADA2025 @amdiabetesassn.bsky.social
June 22, 2025 at 11:36 AM
The Banting Award for scientific achievement to Professor Steven Kahn. A stellar career with scientific leadership across multiple domains #diabetes A poignant celebration unfolds #ADA2025 @amdiabetesassn.bsky.social
At #ADA2025, Dr. Rita Rastogi Kalyani reminded us that diabetes progress must be global—many still lack access to basic care. Let’s scale GLP-1s, SGLT2is, and training for all.
@amdiabetesassn.bsky.social
#ADASciSessions #diabetesleadership #healthaccess
@amdiabetesassn.bsky.social
#ADASciSessions #diabetesleadership #healthaccess
June 23, 2025 at 3:58 AM
At #ADA2025, Dr. Rita Rastogi Kalyani reminded us that diabetes progress must be global—many still lack access to basic care. Let’s scale GLP-1s, SGLT2is, and training for all.
@amdiabetesassn.bsky.social
#ADASciSessions #diabetesleadership #healthaccess
@amdiabetesassn.bsky.social
#ADASciSessions #diabetesleadership #healthaccess
A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found. #ADA2025
www.medpagetoday.com/meetingcover...
www.medpagetoday.com/meetingcover...
Once-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes
Insulin efsitora may potentially change the management paradigm, researcher says
www.medpagetoday.com
June 23, 2025 at 3:23 PM
A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found. #ADA2025
www.medpagetoday.com/meetingcover...
www.medpagetoday.com/meetingcover...
Also read the Linked Comment by Tricia M-M Tan:
Is biased agonism helpful in the treatment of obesity with the GLP-1 receptor analogues? thelancet.com/journals/lan...
#ADA2025 @AmDiabetesAssn #ADASciSessions
#MedSky #EndoSky
Is biased agonism helpful in the treatment of obesity with the GLP-1 receptor analogues? thelancet.com/journals/lan...
#ADA2025 @AmDiabetesAssn #ADASciSessions
#MedSky #EndoSky
Is biased agonism helpful in the treatment of obesity with the GLP-1 receptor analogues?
Obesity, overweight, and the consequences of excess adiposity continue to drive a
substantial proportion of morbidity and mortality around the world. Prevention and
treatment of obesity is an importan...
thelancet.com
June 21, 2025 at 7:53 PM
Also read the Linked Comment by Tricia M-M Tan:
Is biased agonism helpful in the treatment of obesity with the GLP-1 receptor analogues? thelancet.com/journals/lan...
#ADA2025 @AmDiabetesAssn #ADASciSessions
#MedSky #EndoSky
Is biased agonism helpful in the treatment of obesity with the GLP-1 receptor analogues? thelancet.com/journals/lan...
#ADA2025 @AmDiabetesAssn #ADASciSessions
#MedSky #EndoSky
📍 Attending #ADASciSessions? The #NIDDK #DataScience Corner is your one-stop hub for datasets, tools, and expert connections at #ADA2025!
Meet teams from dkNET, NIDDK-CR, PanKbase, HIRN, CMD-KP, IIDP, MMPC, TEDDY, RADIANT, TrialNet, CODA — all in one space
🔗 dknet.org/data-science...
#diabetes
Meet teams from dkNET, NIDDK-CR, PanKbase, HIRN, CMD-KP, IIDP, MMPC, TEDDY, RADIANT, TrialNet, CODA — all in one space
🔗 dknet.org/data-science...
#diabetes
June 19, 2025 at 4:05 PM
📍 Attending #ADASciSessions? The #NIDDK #DataScience Corner is your one-stop hub for datasets, tools, and expert connections at #ADA2025!
Meet teams from dkNET, NIDDK-CR, PanKbase, HIRN, CMD-KP, IIDP, MMPC, TEDDY, RADIANT, TrialNet, CODA — all in one space
🔗 dknet.org/data-science...
#diabetes
Meet teams from dkNET, NIDDK-CR, PanKbase, HIRN, CMD-KP, IIDP, MMPC, TEDDY, RADIANT, TrialNet, CODA — all in one space
🔗 dknet.org/data-science...
#diabetes
10 people with type 1 #diabetes have remained insulin-independent for over a year following allogeneic stem cell-derived islet-cell therapy. Story by @miriametucker.bsky.social via @medscape.com from #ADA2025 in Chicago.
#T1D #MedSky #EndoSky #endocrinology
#T1D #MedSky #EndoSky #endocrinology
Stem Cell-Derived Islets Still Producing Insulin at 1 Year
One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 diabetes in whom the benefits outweigh the risks of immunosuppression.
www.medscape.com
June 21, 2025 at 8:25 PM
10 people with type 1 #diabetes have remained insulin-independent for over a year following allogeneic stem cell-derived islet-cell therapy. Story by @miriametucker.bsky.social via @medscape.com from #ADA2025 in Chicago.
#T1D #MedSky #EndoSky #endocrinology
#T1D #MedSky #EndoSky #endocrinology
Final day at #ADA2025 #ADASciSessions! Stop by the #NIDDK #DataScience Corner to connect with teams offering tools, datasets & resources: #dkNET, NIDDK-CR, PanKbase, HIRN, CMDKP, IIDP, MMPC, TEDDY, RADIANT, TrialNet & CODA — all in one space! 🔗 dknet.org/data-science...
June 23, 2025 at 2:55 PM
Final day at #ADA2025 #ADASciSessions! Stop by the #NIDDK #DataScience Corner to connect with teams offering tools, datasets & resources: #dkNET, NIDDK-CR, PanKbase, HIRN, CMDKP, IIDP, MMPC, TEDDY, RADIANT, TrialNet & CODA — all in one space! 🔗 dknet.org/data-science...
🎶 I may not sing like most folks—but I do drop country music with heart, twang, and tech.
Speech impairment? Yep.
Love for real country music? Bigger than Oklahoma's heart.
🎧 Crank it up here: linktr.ee/RichardAnder...
#thatlonesomewind #RichardAnderson #ADA2025 #aiartist #NowPlaying
Speech impairment? Yep.
Love for real country music? Bigger than Oklahoma's heart.
🎧 Crank it up here: linktr.ee/RichardAnder...
#thatlonesomewind #RichardAnderson #ADA2025 #aiartist #NowPlaying
Richard Anderson | Facebook | Linktree
View RichardAnderson’s Linktree to discover and stream music from top platforms like YouTube, Spotify, Apple Music here. Your next favorite track is just a click away!
linktr.ee
June 28, 2025 at 6:43 PM
🎶 I may not sing like most folks—but I do drop country music with heart, twang, and tech.
Speech impairment? Yep.
Love for real country music? Bigger than Oklahoma's heart.
🎧 Crank it up here: linktr.ee/RichardAnder...
#thatlonesomewind #RichardAnderson #ADA2025 #aiartist #NowPlaying
Speech impairment? Yep.
Love for real country music? Bigger than Oklahoma's heart.
🎧 Crank it up here: linktr.ee/RichardAnder...
#thatlonesomewind #RichardAnderson #ADA2025 #aiartist #NowPlaying
Leslie Lange at #ADA2025: PRS must account for genetic ancestry to be valid across diverse populations. GWAS loci ≠ always functional.
@amdiabetesassn.bsky.social
#ADASciSessions #PRS #genetics #ancestryinresearch
@amdiabetesassn.bsky.social
#ADASciSessions #PRS #genetics #ancestryinresearch
June 23, 2025 at 4:06 AM
Leslie Lange at #ADA2025: PRS must account for genetic ancestry to be valid across diverse populations. GWAS loci ≠ always functional.
@amdiabetesassn.bsky.social
#ADASciSessions #PRS #genetics #ancestryinresearch
@amdiabetesassn.bsky.social
#ADASciSessions #PRS #genetics #ancestryinresearch
Dr. Anna Gloyn at #ADA2025: Multiomic data reveals diabetes heterogeneity, linking polygenic scores, islet traits, and regulatory networks.
@amdiabetesassn.bsky.social @annagloyn.bsky.social
#ADASciSessions #T2D #genomics #multiomics
@amdiabetesassn.bsky.social @annagloyn.bsky.social
#ADASciSessions #T2D #genomics #multiomics
June 23, 2025 at 4:04 AM
Dr. Anna Gloyn at #ADA2025: Multiomic data reveals diabetes heterogeneity, linking polygenic scores, islet traits, and regulatory networks.
@amdiabetesassn.bsky.social @annagloyn.bsky.social
#ADASciSessions #T2D #genomics #multiomics
@amdiabetesassn.bsky.social @annagloyn.bsky.social
#ADASciSessions #T2D #genomics #multiomics
Grateful and excited to attend #ADA2025 as a #dedoc° voice, thanks to the #dedocVoices Scholarship Program! Thanks to the #dedoc Diabetes Online Community for this opportunity. Views are my own.// ¡Muy agradecida y emocionada de asistir a #ADA2025 como voz #dedoc°! #payitforward
June 16, 2025 at 4:08 PM
Grateful and excited to attend #ADA2025 as a #dedoc° voice, thanks to the #dedocVoices Scholarship Program! Thanks to the #dedoc Diabetes Online Community for this opportunity. Views are my own.// ¡Muy agradecida y emocionada de asistir a #ADA2025 como voz #dedoc°! #payitforward
P3 CagriSema in adults with overweight #obesity Placebo subtracted #weightloss of 17.3%; 60.2% & 40.4% achieved 20% and 25% weight loss, respectively @amdiabetesassn.bsky.social #ADA2025 www.nejm.org/doi/full/10....
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity | NEJM
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits,
and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials;
the efficacy of the ...
www.nejm.org
June 22, 2025 at 1:20 PM
P3 CagriSema in adults with overweight #obesity Placebo subtracted #weightloss of 17.3%; 60.2% & 40.4% achieved 20% and 25% weight loss, respectively @amdiabetesassn.bsky.social #ADA2025 www.nejm.org/doi/full/10....
“Be aware of structural barriers to GLP-1 access.” Dr. Jaclynn Hawkins at #ADA2025 urged action to close equity gaps in obesity care.
@amdiabetesassn.bsky.social
#ADASciSessions #GLP1 #healthjustice
@amdiabetesassn.bsky.social
#ADASciSessions #GLP1 #healthjustice
June 22, 2025 at 5:48 AM
“Be aware of structural barriers to GLP-1 access.” Dr. Jaclynn Hawkins at #ADA2025 urged action to close equity gaps in obesity care.
@amdiabetesassn.bsky.social
#ADASciSessions #GLP1 #healthjustice
@amdiabetesassn.bsky.social
#ADASciSessions #GLP1 #healthjustice
Planning your #ADA2025 visit? Don’t miss the NIDDK #DataScience Corner hosted by #dkNET!
📍 Between ADA Member Lounge & Product Theater 1
🗓 Visit during the reception or exhibit hours
🎉 Celebrate 75 years of #NIDDK!
🔗 dknet.org/data-science...
#ADASciSessions
📍 Between ADA Member Lounge & Product Theater 1
🗓 Visit during the reception or exhibit hours
🎉 Celebrate 75 years of #NIDDK!
🔗 dknet.org/data-science...
#ADASciSessions
June 17, 2025 at 2:45 PM
Planning your #ADA2025 visit? Don’t miss the NIDDK #DataScience Corner hosted by #dkNET!
📍 Between ADA Member Lounge & Product Theater 1
🗓 Visit during the reception or exhibit hours
🎉 Celebrate 75 years of #NIDDK!
🔗 dknet.org/data-science...
#ADASciSessions
📍 Between ADA Member Lounge & Product Theater 1
🗓 Visit during the reception or exhibit hours
🎉 Celebrate 75 years of #NIDDK!
🔗 dknet.org/data-science...
#ADASciSessions
On this day in 1990, President George H.W. Bush signed the landmark disability rights law known as the Americans with Disabilities Act (ADA). The ADA turns 35 today, and we remain committed to fulfilling Justin Dart, Jr.'s dream! 🧑🦼👩🦽👨🦯🦾🦮🐕🦺♿️ #ada2025 #ThanksToTheADA #ada35 #ADAanniversary
June 26, 2025 at 4:25 PM
On this day in 1990, President George H.W. Bush signed the landmark disability rights law known as the Americans with Disabilities Act (ADA). The ADA turns 35 today, and we remain committed to fulfilling Justin Dart, Jr.'s dream! 🧑🦼👩🦽👨🦯🦾🦮🐕🦺♿️ #ada2025 #ThanksToTheADA #ada35 #ADAanniversary
DT1 : les îlots pancréatiques dérivés de cellules souches continuent de produire de l'insuline après un an #ADA2025
http://ms.spr.ly/63321S2X7F
http://ms.spr.ly/63321S2X7F
DT1 : les îlots pancréatiques dérivés de cellules souches continuent de produire de l'insuline après un an
Des données à un an suggèrent que la thérapie à base de cellules d'îlots pancréatiques dérivées de cellules souches allogéniques pourrait devenir une option d'avenir pour les patients diabétiques de type 1 chez lesquels les avantages l'emportent sur les risques liés à l'immunosuppression.
ms.spr.ly
July 3, 2025 at 1:55 PM
DT1 : les îlots pancréatiques dérivés de cellules souches continuent de produire de l'insuline après un an #ADA2025
http://ms.spr.ly/63321S2X7F
http://ms.spr.ly/63321S2X7F
An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage type 2 diabetes, a phase III randomized trial found. #ADA2025
www.medpagetoday.com/meetingcover...
www.medpagetoday.com/meetingcover...
Novel Oral GLP-1 Agent Cuts A1c, Weight in Early Diabetes
Pill doesn't carry same food intake restrictions as oral semaglutide
www.medpagetoday.com
June 23, 2025 at 3:21 PM
An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage type 2 diabetes, a phase III randomized trial found. #ADA2025
www.medpagetoday.com/meetingcover...
www.medpagetoday.com/meetingcover...
Sketched highlights from a #ADA2025 session on real-world AID systems! 🔄 From Bionic Pancreas to Tandem & Omnipod 5—encouraging outcomes across ages and types.
#ADASciSessions @amdiabetesassn.bsky.social
#ADASciSessions @amdiabetesassn.bsky.social
June 21, 2025 at 5:09 AM
Sketched highlights from a #ADA2025 session on real-world AID systems! 🔄 From Bionic Pancreas to Tandem & Omnipod 5—encouraging outcomes across ages and types.
#ADASciSessions @amdiabetesassn.bsky.social
#ADASciSessions @amdiabetesassn.bsky.social